An adenoviral system for tetracycline-regulated TGF-β expression mediates a reversible cell cycle arrest

European Journal of Oral Sciences

Volumn 109, Issue 6, 2001, Pages 415-421

  Wettergreen, Matthew A ^a   Hunniford, John W ^a   Crawford, John M ^a   Adami, Guy R ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b M/C 838 ^*  (United States)

Author keywords

Adenovirus; Cell cycle; Primary oral keratinocytes; Tetracycline; Transforming growth factor

Indexed keywords

RECOMBINANT PROTEIN; TETRACYCLINE; TRANS ACTIVATORS; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CYTOLOGY; DNA VECTOR; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; GENETICS; HUMAN; PHYSIOLOGY; PROMOTER REGION; TRANSGENE;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; CELL CYCLE; EPITHELIAL CELLS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMAN; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; TETRACYCLINE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 0035654492     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1034/j.1600-0722.2001.00105.x     Document Type: Article

References (46)

1. RUSCETTI FW, BIRCHENALL-ROBERTS MC, MCPHERSON JM, WILTROUT RH. Transforming growth factor beta. In: MIRE-SLUIS A, THORPE R, eds. Cytokines. San Diego: Academic Press, 1998: 415-432.
2. HURATA H, LIU CB, VALKOVA J, KOCH AE, YSSEL H, HIRABAYASHI Y, INOUE T, YOKOTA T, ARAI K. Recombinant adenovirus vectors for cytokine gene therapy in mice. J Allergy Clin Immunol 1999; 103: S471-S484.
3. MEHRARA BJ, SAADEH PB, STEINBRECH DS, DUDZIAK M, SPECTOR JA, GREENWALD JA, GITTES GK, LONGAKER MT. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo. J Bone Miner Res 1999; 14: 1290-1301.
4. ARAI Y, KUBO T, KOBAYASHI K, TAKESHITA K, TAKAHASHI K, IKEDA T, IMANISHI J, TAKIGAWA M, HIRASAWA Y. Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. J Rheumatol 1997; 24: 1787-1795.
5. BALTZER AW, LATTERMAN C, WHALEN JD, GHIVIZZANI S, WOOLEY P, KRAUSPE R, ROBBINS PD, EVANS CH. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop 2000; 379 (Suppl): S120-S125.
6. JOSIEN R, DOUILLARD P, GUILLOT C, MUSCHEN M, ANEGON I, CHETRITT J, MENORET S, VIGNES C, SOULILLOU JP, CUTURI MC. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998; 102: 1920-1926.
7. WANG S, BAUM BJ, YAMANO S, MANKANI MH, SUN D, JONSSON M, DAVIS C, GRAHAM FL, GAULDIE J, ATKINSON JC. Adenoviral-mediated gene transfer to mouse salivary glands. J Dent Res 2000; 79: 701-708.
8. IKEDA T, KUBO T, ARAI Y, NAKANISHI T, KOBAYASHI K, TAKAHASHI K, IMANISHI J, TAKIGAWA M, HIRASAWA Y. Adenovirus mediated gene delivery to the joints of guinea pigs. J Rheumatol 1998; 25: 1666-1673.
9. MASSAGUE J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-791.
10. MASSAGUE J, POLYAK K. Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev 1995; 5: 91-96.
11. ALEXANDROW MG, MOSES HL. Transforming growth factor beta and cell cycle regulation. Cancer Res 1995; 55: 1452-1457.
12. STONE S, DAYANANTH P, KAMB A. Reversible p16-mediated cell cycle arrest as protection from chemotherapy. Cancer Res 1996; 56: 3199-3202.
13. WEYMAN CM, STACEY DW. Transient blockage of proliferative signalling: a novel strategy for protective chemotherapy. Anticancer Res 1996; 16: 493-498.
14. MCCORMACK ES, BORZILLO GV, AMBROSINO C, MAK G, HAMABLET L, QU GY, HALEY JD. Transforming growth factor-beta 3 protection of epithelial cells from cycle-selective chemotherapy in vitro. Biochem Pharmacol 1997; 53: 1149-1159.
15. SONIS ST, VAN VUGT AG, BRIEN JP, MUSKA AD, BRUSKIN AM, ROSE A, HALEY JD. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol 1997; 33: 47-54.
16. POTTEN CS, BOOTH D, HALEY JD. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 1997; 75: 1454-1459.
17. COMMITTEE ON RESEARCH, AMERICAN ACADEMY OF PERIODONTOLOGY. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol 1996; 67: 545-553.
18. MASTRANGELLI A, O'CONNELL B, ALADIB W, FOX PC, BAUM BJ, CRYSTAL RG. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 1994; 266: G1146-G1155.
19. TERAMOTO S, JOHNSON LG, HUANG W, LEIGH MW, BOUCHER RC. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther 1995; 6: 1045-1053.
20. WERSTO RP, ROSENTHAL ER, SETH PK, EISSA NT, DONAHUE RE. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 1998; 72: 9491-9502.
21. GINSBERG HS. The ups and downs of adenovirus vectors. Bull NY Acad Med 1996; 73: 53-58.
22. CORTI O, SABATE O, HORELLOU P, COLIN P, DUMAS S, BUCHET D, BUCCARON MH, MALLET J. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain crafts of human neural progenitors. Nat Biotechnol 1999; 17: 349-354.
23. HARDING TC, GEDDES BJ, MURPHY D, KNIGHT D, UNEY JB. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol 1998; 16: 553-555.
24. HU SX, JI W, ZHOU Y, LOGOTHETIS C, XU HJ. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res 1997; 57: 3339-3343.
25. YOSHIDA Y, HAMADA H. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun 1997; 230: 426-430.
26. NEERING SJ, HARDY SF, MINAMOTO D, SPRATT SK, JORDAN CT. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996; 88: 1147-1155.
27. GOSSEN M, BUJARD H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
28. SCHWARZ JK, BASSING CH, KOVESDI I, DATTO MB, BLAZING M, GEORGE S, WANG X, NEVINS JR. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 1995; 92: 483-487.
29. BRUNNER AM, MARQUARDT H, MALACKO AR, LIOUBIN MN, PURCHIO AF. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J Biol Chem 1989; 264: 13660-13664.
30. GRAHAM F, VAN DER EB AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
31. MORSY MA, ALFORD EL, BETT A, GRAHAM FL, CASKEY CT. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest 1993; 92: 1580-1586.
32. ODA D, WATSON E. Human oral epithelial cell culture I. Improved conditions for reproducible culture in serum-free medium. In Vitro Cell Dev Biol 1990; 26: 589-595.
33. PARK NH, MIN BM, LI SL, HUANG MZ, CHERICK HM, DONIGER J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991; 12: 1627-1631.
34. QIAN SW, BURMESTER JK, SUN PD, HUANG A, OHLSEN DJ, SUARDET L, FLANDERS KC, DAVIES D, ROBERTS AB, SPORN MB. Characterization of mutated transforming growth factor-beta s which possess unique biological properties. Biochemistry 1994; 33: 12298-12304.
35. MUHLHAUSER J, PILI R, MERRILL MJ, MAEDA H, PASSANITI A, CRYSTAL RG, CAPOGROSSI MC. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum Gene Ther 1995; 6: 1457-1465.
36. NAKANISHI T, NISHIDA T, SHIMO T, KOBAYASHI K, KUBO T, TAMATANI T, TEZUKA K, TAKIGAWA M. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 2000; 141: 264-273.
37. TAIPALE J, SAHARINEN J, KESKI-OJA J. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res 1998; 75: 87-134.
38. O'CONNELL AC, BACCAGLINI L, FOX PC, O'CONNELL BC, KENSHALO D, OWEISY H, HOQUE AT, SUN D, HERSCHER LL, BRADDON VR, DELPORTE C, BAUM BJ. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther 1999; 6: 505-513.
39. WANG S, BAUM BJ, KAGAMI H, ZHENG C, O'CONNELL BC, ATKINSON JC. Effect of clodronate on macrophage depletion and adenoviral-mediated transgene expression in salivary glands. J Oral Pathol Med 1999; 28: 145-151.
40. GOTTLOW J, NYMAN S, KARRING T. New attachment formation as the result of controlled tissue regeneration. J Clin Periodontol 1984; 11: 494-503.
41. NYMAN S, LINDHE J, KARRING T, RYLANDER H. New attachment following surgical treamtent of human periodontal disease. J Clin Periodontol 1982; 9: 290-296.
42. NYMAN S, GOTTLOW J, LINDHE J, KARRING T, WENNSTROM J. New attachment formation by guided tissue regeneration. J Periodont Res 1987; 22: 252-254.
43. GIANNOBILE WV, RYAN S, SHIH M-S, SU DL, KAPLAN PL, CHAN TCK. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol 1998; 69: 129-137.
44. HOWELL TH, FIORELLINI JP, PAQUETTE DW, OFFENBACHER S, GIANNOBILE WV, LYNCH SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor BB and recombinant insulin-like growth factor I in patients with periodontal diseases. J Periodontol 1997; 68: 1186-1193.
45. LYNCH SE, WILLIAMS RC, POLSON AM, HOWELL TH, REDDY MS, ZAPPA UE, ANTONIADES HN. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989; 16: 545-548.
46. LYNCH SE, RUIZ DE CASTAILLA G, WILLIAMS RC, KIRITSY CP, HOWELL TH, REDDY MS, ANTONIADES HN. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on a periodontal wound healing. J Periodontol 1991; 62: 458-467.